Hundred nanogram of unspecific siRNA ( control), Sp1 - specific siRNA ( Sp1), Sp3 - specific siRNA ( Sp3) or a mixture of 50 ng Sp1 - specific plus 50 ng Sp3 - specific siRNA ( Sp1 + Sp3) were used.	"Sp1	49	52	Protein"	"Sp1	72	75	Protein"	"Sp3	78	81	Protein"	"Sp3	101	104	Protein"	"Sp1	128	131	Protein"	"Sp3	154	157	Protein"	"Sp1	177	180	Protein"	"Sp3	183	186	Protein"	"[{""token"": ""Sp1"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Protein""}, {""token"": ""Sp1"", ""start_span"": 72, ""end_span"": 75, ""type"": ""Protein""}, {""token"": ""Sp3"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Protein""}, {""token"": ""Sp3"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Protein""}, {""token"": ""Sp1"", ""start_span"": 128, ""end_span"": 131, ""type"": ""Protein""}, {""token"": ""Sp3"", ""start_span"": 154, ""end_span"": 157, ""type"": ""Protein""}, {""token"": ""Sp1"", ""start_span"": 177, ""end_span"": 180, ""type"": ""Protein""}, {""token"": ""Sp3"", ""start_span"": 183, ""end_span"": 186, ""type"": ""Protein""}]"
However, BCR - induced Erk phosphorylation was also reduced in PKD1 / 3 - / - - Flag - PKD3 + B cells ( data not shown) suggesting that reduced BCR levels on the surface of PKD1 / 3 - / - ( and PKD1 / 3 - / - - Flag - PKD3 +) B cells may itself impact on the strength of activation of this specific intracellular signalling pathway.	"PKD1	63	67	Protein"	"3	70	71	Protein"	"PKD3	87	91	Protein"	"PKD1	173	177	Protein"	"3	180	181	Protein"	"PKD1	194	198	Protein"	"3	201	202	Protein"	"PKD3	218	222	Protein"	"[{""token"": ""PKD1"", ""start_span"": 63, ""end_span"": 67, ""type"": ""Protein""}, {""token"": ""3"", ""start_span"": 70, ""end_span"": 71, ""type"": ""Protein""}, {""token"": ""PKD3"", ""start_span"": 87, ""end_span"": 91, ""type"": ""Protein""}, {""token"": ""PKD1"", ""start_span"": 173, ""end_span"": 177, ""type"": ""Protein""}, {""token"": ""3"", ""start_span"": 180, ""end_span"": 181, ""type"": ""Protein""}, {""token"": ""PKD1"", ""start_span"": 194, ""end_span"": 198, ""type"": ""Protein""}, {""token"": ""3"", ""start_span"": 201, ""end_span"": 202, ""type"": ""Protein""}, {""token"": ""PKD3"", ""start_span"": 218, ""end_span"": 222, ""type"": ""Protein""}]"
The IL - 4 + cells were confined to the FOXP3 - cells, as shown for the CD45RO + CD25 -, CD45RO + CD25 +, and CD45RO + CD25 + high cells ( Figure 3B).	"IL - 4	4	10	Protein"	"FOXP3	40	45	Protein"	"CD45RO	72	78	Protein"	"CD25	81	85	Protein"	"CD45RO	89	95	Protein"	"CD25	98	102	Protein"	"CD45RO	110	116	Protein"	"CD25	119	123	Protein"	"[{""token"": ""IL - 4"", ""start_span"": 4, ""end_span"": 10, ""type"": ""Protein""}, {""token"": ""FOXP3"", ""start_span"": 40, ""end_span"": 45, ""type"": ""Protein""}, {""token"": ""CD45RO"", ""start_span"": 72, ""end_span"": 78, ""type"": ""Protein""}, {""token"": ""CD25"", ""start_span"": 81, ""end_span"": 85, ""type"": ""Protein""}, {""token"": ""CD45RO"", ""start_span"": 89, ""end_span"": 95, ""type"": ""Protein""}, {""token"": ""CD25"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Protein""}, {""token"": ""CD45RO"", ""start_span"": 110, ""end_span"": 116, ""type"": ""Protein""}, {""token"": ""CD25"", ""start_span"": 119, ""end_span"": 123, ""type"": ""Protein""}]"
The IL - 4 - mediated prevention of FOXP3 expression was not caused by interferences of the receptor signaling, because the phosphorylation of SMAD2 or STAT6 was not affected by the addition of IL - 4 and / or TGF - beta, which demonstrates that IL - 4 as well as TGF - beta signaling were functional under these conditions ( Figure 5C).	"IL - 4	4	10	Protein"	"FOXP3	36	41	Protein"	"SMAD2	143	148	Protein"	"STAT6	152	157	Protein"	"IL - 4	194	200	Protein"	"TGF - beta	210	220	Protein"	"IL - 4	246	252	Protein"	"TGF - beta	264	274	Protein"	"[{""token"": ""IL - 4"", ""start_span"": 4, ""end_span"": 10, ""type"": ""Protein""}, {""token"": ""FOXP3"", ""start_span"": 36, ""end_span"": 41, ""type"": ""Protein""}, {""token"": ""SMAD2"", ""start_span"": 143, ""end_span"": 148, ""type"": ""Protein""}, {""token"": ""STAT6"", ""start_span"": 152, ""end_span"": 157, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 194, ""end_span"": 200, ""type"": ""Protein""}, {""token"": ""TGF - beta"", ""start_span"": 210, ""end_span"": 220, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 246, ""end_span"": 252, ""type"": ""Protein""}, {""token"": ""TGF - beta"", ""start_span"": 264, ""end_span"": 274, ""type"": ""Protein""}]"
Although TGF - beta - reduced CD25, IL - 4 expression, and CD25 expression ( Figure 6B), IL - 4 significantly inhibited TGF - beta - mediated induction of FOXP3 in naive T cells driven toward FOXP3 + T cells, as shown by FACS analysis ( Figure 6A).	"TGF - beta	9	19	Protein"	"CD25	30	34	Protein"	"IL - 4	36	42	Protein"	"CD25	59	63	Protein"	"IL - 4	89	95	Protein"	"TGF - beta	120	130	Protein"	"FOXP3	155	160	Protein"	"FOXP3	192	197	Protein"	"[{""token"": ""TGF - beta"", ""start_span"": 9, ""end_span"": 19, ""type"": ""Protein""}, {""token"": ""CD25"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 36, ""end_span"": 42, ""type"": ""Protein""}, {""token"": ""CD25"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 89, ""end_span"": 95, ""type"": ""Protein""}, {""token"": ""TGF - beta"", ""start_span"": 120, ""end_span"": 130, ""type"": ""Protein""}, {""token"": ""FOXP3"", ""start_span"": 155, ""end_span"": 160, ""type"": ""Protein""}, {""token"": ""FOXP3"", ""start_span"": 192, ""end_span"": 197, ""type"": ""Protein""}]"
Furthermore the TGF - beta - mediated induction of FOXP3 expression was not caused by overgrowth of a CD25 - FOXP3 + minority, since the number of FOXP3 + cells was low / absent in the purified CD4 + CD45RA + T cells ( between 0% and 1%), and the FOXP3 + cells were not confined to the highly divided cells.	"TGF - beta	16	26	Protein"	"FOXP3	51	56	Protein"	"CD25	102	106	Protein"	"FOXP3	109	114	Protein"	"FOXP3	147	152	Protein"	"CD4	194	197	Protein"	"CD45RA	200	206	Protein"	"FOXP3	247	252	Protein"	"[{""token"": ""TGF - beta"", ""start_span"": 16, ""end_span"": 26, ""type"": ""Protein""}, {""token"": ""FOXP3"", ""start_span"": 51, ""end_span"": 56, ""type"": ""Protein""}, {""token"": ""CD25"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Protein""}, {""token"": ""FOXP3"", ""start_span"": 109, ""end_span"": 114, ""type"": ""Protein""}, {""token"": ""FOXP3"", ""start_span"": 147, ""end_span"": 152, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 194, ""end_span"": 197, ""type"": ""Protein""}, {""token"": ""CD45RA"", ""start_span"": 200, ""end_span"": 206, ""type"": ""Protein""}, {""token"": ""FOXP3"", ""start_span"": 247, ""end_span"": 252, ""type"": ""Protein""}]"
( C) Kinetic analysis of intracellular GATA3 and FOXP3 staining is shown in panel C following exposure of CD4 + CD45RA + T cells to anti - CD3 / 28, IL - 4 and TGF - beta.	"GATA3	39	44	Protein"	"FOXP3	49	54	Protein"	"CD4	106	109	Protein"	"CD45RA	112	118	Protein"	"CD3	139	142	Protein"	"28	145	147	Protein"	"IL - 4	149	155	Protein"	"TGF - beta	160	170	Protein"	"[{""token"": ""GATA3"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Protein""}, {""token"": ""FOXP3"", ""start_span"": 49, ""end_span"": 54, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Protein""}, {""token"": ""CD45RA"", ""start_span"": 112, ""end_span"": 118, ""type"": ""Protein""}, {""token"": ""CD3"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Protein""}, {""token"": ""28"", ""start_span"": 145, ""end_span"": 147, ""type"": ""Protein""}, {""token"": ""IL - 4"", ""start_span"": 149, ""end_span"": 155, ""type"": ""Protein""}, {""token"": ""TGF - beta"", ""start_span"": 160, ""end_span"": 170, ""type"": ""Protein""}]"
Circulating human CD4 + CD25high CD127 - T reg cells significantly expressed higher levels of RUNX3, FOXP3, and TGF - beta mRNA compared with CD4 + CD25 - cells.	"CD4	18	21	Protein"	"CD25high	24	32	Protein"	"CD127	33	38	Protein"	"RUNX3	94	99	Protein"	"FOXP3	101	106	Protein"	"TGF - beta	112	122	Protein"	"CD4	142	145	Protein"	"CD25	148	152	Protein"	"[{""token"": ""CD4"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Protein""}, {""token"": ""CD25high"", ""start_span"": 24, ""end_span"": 32, ""type"": ""Protein""}, {""token"": ""CD127"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Protein""}, {""token"": ""RUNX3"", ""start_span"": 94, ""end_span"": 99, ""type"": ""Protein""}, {""token"": ""FOXP3"", ""start_span"": 101, ""end_span"": 106, ""type"": ""Protein""}, {""token"": ""TGF - beta"", ""start_span"": 112, ""end_span"": 122, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Protein""}, {""token"": ""CD25"", ""start_span"": 148, ""end_span"": 152, ""type"": ""Protein""}]"
In contrast, the combination of both TGF - beta and anti - CD2 / 3 / 28 mAbs induced RUNX1 and RUNX3 mRNAs, as well as FOXP3 mRNA, within 48 h in naive CD4 + T cells.	"TGF - beta	37	47	Protein"	"CD2	59	62	Protein"	"3	65	66	Protein"	"28	69	71	Protein"	"RUNX1	85	90	Protein"	"RUNX3	95	100	Protein"	"FOXP3	119	124	Protein"	"CD4	152	155	Protein"	"[{""token"": ""TGF - beta"", ""start_span"": 37, ""end_span"": 47, ""type"": ""Protein""}, {""token"": ""CD2"", ""start_span"": 59, ""end_span"": 62, ""type"": ""Protein""}, {""token"": ""3"", ""start_span"": 65, ""end_span"": 66, ""type"": ""Protein""}, {""token"": ""28"", ""start_span"": 69, ""end_span"": 71, ""type"": ""Protein""}, {""token"": ""RUNX1"", ""start_span"": 85, ""end_span"": 90, ""type"": ""Protein""}, {""token"": ""RUNX3"", ""start_span"": 95, ""end_span"": 100, ""type"": ""Protein""}, {""token"": ""FOXP3"", ""start_span"": 119, ""end_span"": 124, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Protein""}]"
To determine whether RUNX1 and RUNX3 are also expressed in human T reg cells in vivo, we isolated peripheral blood CD4 + CD127 - CD25high T reg cells and compared them with CD4 + CD127 + CD25 - T cells.	"RUNX1	21	26	Protein"	"RUNX3	31	36	Protein"	"CD4	115	118	Protein"	"CD127	121	126	Protein"	"CD25high	129	137	Protein"	"CD4	173	176	Protein"	"CD127	179	184	Protein"	"CD25	187	191	Protein"	"[{""token"": ""RUNX1"", ""start_span"": 21, ""end_span"": 26, ""type"": ""Protein""}, {""token"": ""RUNX3"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 115, ""end_span"": 118, ""type"": ""Protein""}, {""token"": ""CD127"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Protein""}, {""token"": ""CD25high"", ""start_span"": 129, ""end_span"": 137, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 173, ""end_span"": 176, ""type"": ""Protein""}, {""token"": ""CD127"", ""start_span"": 179, ""end_span"": 184, ""type"": ""Protein""}, {""token"": ""CD25"", ""start_span"": 187, ""end_span"": 191, ""type"": ""Protein""}]"
For the in vivo Foxp3 conversion assay, naive CD4 + T cells from Cbfb CD4 - cre or control mice ( harboring a Foxp3 - IRES - GFP allele) were adoptively transferred into Rag - deficient mice.	"Foxp3	16	21	Protein"	"CD4	46	49	Protein"	"Cbfb	65	69	Protein"	"CD4	70	73	Protein"	"cre	76	79	Protein"	"Foxp3	110	115	Protein"	"GFP	125	128	Protein"	"Rag	170	173	Protein"	"[{""token"": ""Foxp3"", ""start_span"": 16, ""end_span"": 21, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Protein""}, {""token"": ""Cbfb"", ""start_span"": 65, ""end_span"": 69, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 70, ""end_span"": 73, ""type"": ""Protein""}, {""token"": ""cre"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Protein""}, {""token"": ""Foxp3"", ""start_span"": 110, ""end_span"": 115, ""type"": ""Protein""}, {""token"": ""GFP"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Protein""}, {""token"": ""Rag"", ""start_span"": 170, ""end_span"": 173, ""type"": ""Protein""}]"
To evaluate the effect of overexpression of RUNX1 or RUNX3 on FOXP3 protein levels, CD4 + T cells were preactivated with 2 microg / ml phytohemagglutinin ( Sigma - Aldrich) in serum - free AIM - V medium in the presence of 1 nmol / liter IL - 2 ( Roche) for 12 h, and then transfected with the vector pEGFPN1 containing the RUNX1 or RUNX3 fragment using the Nucleofector system ( Amaxa Biosystems) and the program T - 23.	"RUNX1	44	49	Protein"	"RUNX3	53	58	Protein"	"FOXP3	62	67	Protein"	"CD4	84	87	Protein"	"phytohemagglutinin	135	153	Protein"	"IL - 2	238	244	Protein"	"RUNX1	324	329	Protein"	"RUNX3	333	338	Protein"	"[{""token"": ""RUNX1"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Protein""}, {""token"": ""RUNX3"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Protein""}, {""token"": ""FOXP3"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 84, ""end_span"": 87, ""type"": ""Protein""}, {""token"": ""phytohemagglutinin"", ""start_span"": 135, ""end_span"": 153, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 238, ""end_span"": 244, ""type"": ""Protein""}, {""token"": ""RUNX1"", ""start_span"": 324, ""end_span"": 329, ""type"": ""Protein""}, {""token"": ""RUNX3"", ""start_span"": 333, ""end_span"": 338, ""type"": ""Protein""}]"
S1 shows the induction of RUNX1, RUNX3, and FOXP3 mRNA in human CD4 + T cells after anti - CD2 / 3 / 28 mAb and TGF - beta stimulation.	"RUNX1	26	31	Protein"	"RUNX3	33	38	Protein"	"FOXP3	44	49	Protein"	"CD4	64	67	Protein"	"CD2	91	94	Protein"	"3	97	98	Protein"	"28	101	103	Protein"	"TGF - beta	112	122	Protein"	"[{""token"": ""RUNX1"", ""start_span"": 26, ""end_span"": 31, ""type"": ""Protein""}, {""token"": ""RUNX3"", ""start_span"": 33, ""end_span"": 38, ""type"": ""Protein""}, {""token"": ""FOXP3"", ""start_span"": 44, ""end_span"": 49, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 64, ""end_span"": 67, ""type"": ""Protein""}, {""token"": ""CD2"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Protein""}, {""token"": ""3"", ""start_span"": 97, ""end_span"": 98, ""type"": ""Protein""}, {""token"": ""28"", ""start_span"": 101, ""end_span"": 103, ""type"": ""Protein""}, {""token"": ""TGF - beta"", ""start_span"": 112, ""end_span"": 122, ""type"": ""Protein""}]"
S3 shows the quantification of IL - 4, IL - 5, IL - 10, IL - 13, and IFN - gamma levels in control siRNA transfected or RUNX1 and RUNX3 siRNA transfected human CD4 + T cells.	"IL - 4	31	37	Protein"	"IL - 5	39	45	Protein"	"IL - 10	47	54	Protein"	"IL - 13	56	63	Protein"	"IFN - gamma	69	80	Protein"	"RUNX1	120	125	Protein"	"RUNX3	130	135	Protein"	"CD4	160	163	Protein"	"[{""token"": ""IL - 4"", ""start_span"": 31, ""end_span"": 37, ""type"": ""Protein""}, {""token"": ""IL - 5"", ""start_span"": 39, ""end_span"": 45, ""type"": ""Protein""}, {""token"": ""IL - 10"", ""start_span"": 47, ""end_span"": 54, ""type"": ""Protein""}, {""token"": ""IL - 13"", ""start_span"": 56, ""end_span"": 63, ""type"": ""Protein""}, {""token"": ""IFN - gamma"", ""start_span"": 69, ""end_span"": 80, ""type"": ""Protein""}, {""token"": ""RUNX1"", ""start_span"": 120, ""end_span"": 125, ""type"": ""Protein""}, {""token"": ""RUNX3"", ""start_span"": 130, ""end_span"": 135, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 160, ""end_span"": 163, ""type"": ""Protein""}]"
( B) FOXP3 mRNA induction by anti - CD2 / 3 / 28 mAb and TGF - beta in human naive CD4 + T cells is reduced after siRNA - mediated RUNX1 / 3 knockdown.	"FOXP3	5	10	Protein"	"CD2	36	39	Protein"	"3	42	43	Protein"	"28	46	48	Protein"	"TGF - beta	57	67	Protein"	"CD4	83	86	Protein"	"RUNX1	131	136	Protein"	"3	139	140	Protein"	"[{""token"": ""FOXP3"", ""start_span"": 5, ""end_span"": 10, ""type"": ""Protein""}, {""token"": ""CD2"", ""start_span"": 36, ""end_span"": 39, ""type"": ""Protein""}, {""token"": ""3"", ""start_span"": 42, ""end_span"": 43, ""type"": ""Protein""}, {""token"": ""28"", ""start_span"": 46, ""end_span"": 48, ""type"": ""Protein""}, {""token"": ""TGF - beta"", ""start_span"": 57, ""end_span"": 67, ""type"": ""Protein""}, {""token"": ""CD4"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Protein""}, {""token"": ""RUNX1"", ""start_span"": 131, ""end_span"": 136, ""type"": ""Protein""}, {""token"": ""3"", ""start_span"": 139, ""end_span"": 140, ""type"": ""Protein""}]"
Real - time PCR of RNA from human naive CD4 + T cells, transfected with RUNX1 and / or RUNX3 siRNA or with a control siRNA and cultured with anti - CD2 / 3 / 28, TGF - beta and IL - 2.	"CD4	40	43	Protein"	"RUNX1	72	77	Protein"	"RUNX3	87	92	Protein"	"CD2	148	151	Protein"	"3	154	155	Protein"	"28	158	160	Protein"	"TGF - beta	162	172	Protein"	"IL - 2	177	183	Protein"	"[{""token"": ""CD4"", ""start_span"": 40, ""end_span"": 43, ""type"": ""Protein""}, {""token"": ""RUNX1"", ""start_span"": 72, ""end_span"": 77, ""type"": ""Protein""}, {""token"": ""RUNX3"", ""start_span"": 87, ""end_span"": 92, ""type"": ""Protein""}, {""token"": ""CD2"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Protein""}, {""token"": ""3"", ""start_span"": 154, ""end_span"": 155, ""type"": ""Protein""}, {""token"": ""28"", ""start_span"": 158, ""end_span"": 160, ""type"": ""Protein""}, {""token"": ""TGF - beta"", ""start_span"": 162, ""end_span"": 172, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 177, ""end_span"": 183, ""type"": ""Protein""}]"
Human naive CD4 + T cells were transfected with RUNX1 and / or RUNX3 siRNA or with a control siRNA and stimulated with anti - CD2 / 3 / 28 and TGF - beta in the presence of IL - 2.	"CD4	12	15	Protein"	"RUNX1	48	53	Protein"	"RUNX3	63	68	Protein"	"CD2	126	129	Protein"	"3	132	133	Protein"	"28	136	138	Protein"	"TGF - beta	143	153	Protein"	"IL - 2	173	179	Protein"	"[{""token"": ""CD4"", ""start_span"": 12, ""end_span"": 15, ""type"": ""Protein""}, {""token"": ""RUNX1"", ""start_span"": 48, ""end_span"": 53, ""type"": ""Protein""}, {""token"": ""RUNX3"", ""start_span"": 63, ""end_span"": 68, ""type"": ""Protein""}, {""token"": ""CD2"", ""start_span"": 126, ""end_span"": 129, ""type"": ""Protein""}, {""token"": ""3"", ""start_span"": 132, ""end_span"": 133, ""type"": ""Protein""}, {""token"": ""28"", ""start_span"": 136, ""end_span"": 138, ""type"": ""Protein""}, {""token"": ""TGF - beta"", ""start_span"": 143, ""end_span"": 153, ""type"": ""Protein""}, {""token"": ""IL - 2"", ""start_span"": 173, ""end_span"": 179, ""type"": ""Protein""}]"
Moreover, Tat associating with IkappaB - alpha competed the binding of IkappaB - alpha to p65 in a dose - dependent manner ( Figure 3C, lanes 3 - 5), while Tat R ( 49 - 57) A, which lacked the binding site for IkappaB - alpha, did not associate with IkappaB - alpha and did not compete the binding of IkappaB - alpha to p65 ( Figure 3C, lanes 6 - 8).	"Tat	10	13	Protein"	"IkappaB - alpha	31	46	Protein"	"IkappaB - alpha	71	86	Protein"	"p65	90	93	Protein"	"IkappaB - alpha	210	225	Protein"	"IkappaB - alpha	250	265	Protein"	"IkappaB - alpha	301	316	Protein"	"p65	320	323	Protein"	"[{""token"": ""Tat"", ""start_span"": 10, ""end_span"": 13, ""type"": ""Protein""}, {""token"": ""IkappaB - alpha"", ""start_span"": 31, ""end_span"": 46, ""type"": ""Protein""}, {""token"": ""IkappaB - alpha"", ""start_span"": 71, ""end_span"": 86, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 90, ""end_span"": 93, ""type"": ""Protein""}, {""token"": ""IkappaB - alpha"", ""start_span"": 210, ""end_span"": 225, ""type"": ""Protein""}, {""token"": ""IkappaB - alpha"", ""start_span"": 250, ""end_span"": 265, ""type"": ""Protein""}, {""token"": ""IkappaB - alpha"", ""start_span"": 301, ""end_span"": 316, ""type"": ""Protein""}, {""token"": ""p65"", ""start_span"": 320, ""end_span"": 323, ""type"": ""Protein""}]"
Further evidence of Tat activation of NF - kappaB showed that wild - type Tat, and not the Tat mutants lacking the arginine - or cysteine - rich domains, up - regulated in vivo the expression of a number of NF - kappaB - responsive genes, including MIP - 1alpha, CSF3, LTA, NFKBIA and TLR2.	"Tat	20	23	Protein"	"Tat	74	77	Protein"	"Tat mutants	91	102	Protein"	"MIP - 1alpha	249	261	Protein"	"CSF3	263	267	Protein"	"LTA	269	272	Protein"	"NFKBIA	274	280	Protein"	"TLR2	285	289	Protein"	"[{""token"": ""Tat"", ""start_span"": 20, ""end_span"": 23, ""type"": ""Protein""}, {""token"": ""Tat"", ""start_span"": 74, ""end_span"": 77, ""type"": ""Protein""}, {""token"": ""Tat mutants"", ""start_span"": 91, ""end_span"": 102, ""type"": ""Protein""}, {""token"": ""MIP - 1alpha"", ""start_span"": 249, ""end_span"": 261, ""type"": ""Protein""}, {""token"": ""CSF3"", ""start_span"": 263, ""end_span"": 267, ""type"": ""Protein""}, {""token"": ""LTA"", ""start_span"": 269, ""end_span"": 272, ""type"": ""Protein""}, {""token"": ""NFKBIA"", ""start_span"": 274, ""end_span"": 280, ""type"": ""Protein""}, {""token"": ""TLR2"", ""start_span"": 285, ""end_span"": 289, ""type"": ""Protein""}]"
